Lorcaserin for Weight Loss: Insights Into US Food and Drug Administration Approval

被引：11
|
作者：
Miller, Larry E. [1 ]
机构：
[1] Miller Sci Consulting Inc, Arden, NC 28704 USA
来源：
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS | 2013年 / 113卷 / 01期
关键词：
Drug; Lorcaserin; Obesity; Overweight; Weight loss; OBESITY; TRIAL; OVERWEIGHT; AGONIST; ADULTS; RISK;
D O I：
10.1016/j.jand.2012.08.028
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
[No abstract available]
引用
收藏
页码：25 / 30
页数：6
相关论文
共 50 条
  • [21] Radium Ra 223 Dichloride Injection: US Food and Drug Administration Drug Approval Summary
    Kluetz, Paul G.
    Pierce, William
    Maher, V. Ellen
    Zhang, Hui
    Tang, Shenghui
    Song, Pengfei
    Liu, Qi
    Haber, Martin T.
    Leutzinger, Eldon E.
    Al-Hakim, Ali
    Chen, Wei
    Palmby, Todd
    Alebachew, Elleni
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Justice, Robert
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2014, 20 (01) : 9 - 14
  • [22] Food and Drug Administration insights on clinical study of weight-loss devices intended for adolescent patients
    Marrone, April K.
    Venkataraman-Rao, Priya
    Gottschalk, Laura
    PEDIATRIC OBESITY, 2021, 16 (07):
  • [23] THE FOOD-AND-DRUG-ADMINISTRATION DRUG APPROVAL PROCESS
    AHART, GJ
    CONNECTICUT MEDICINE, 1980, 44 (03) : 161 - 166
  • [24] Characteristics of Clinical Trials for the US Food and Drug Administration Accelerated Approval and Subsequent Confirmatory Trials: Implications for Drug Approval in Japan
    Mamiya, Hiroaki
    Narukawa, Mamoru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1345 - 1349
  • [25] Lorcaserin (Belviq) for Weight Loss
    Johnson, Gabrielle
    Oliver, M. Norman
    AMERICAN FAMILY PHYSICIAN, 2014, 90 (12) : 863 - +
  • [26] TRENDS IN APPROVAL OF ADVANCED THERAPY MEDICINAL PRODUCTS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION
    Alsheikh, M. Y.
    Shukla, V
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2018, 21 : S261 - S261
  • [27] US Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
    Singh, Harpreet
    Brave, Michael
    Beaver, Julia A.
    Cheng, Joyce
    Tang, Shenghui
    Zahalka, Eias
    Palmby, Todd R.
    Venugopal, Rajesh
    Song, Pengfei
    Liu, Qi
    Liu, Chao
    Yu, Jingyu
    Chen, Xiao Hong
    Wang, Xing
    Wang, Yaning
    Kluetz, Paul G.
    Daniels, Selena R.
    Papadopoulos, Elektra J.
    Sridhara, Rajeshwari
    Mckee, Amy E.
    Ibrahim, Amna
    Kim, Geoffrey
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 330 - 335
  • [28] US Food and Drug Administration's Approval of Aripiprazole Tablets With Sensor: Our Perspective
    Lee, Daniel J.
    Farchione, Tiffany R.
    Mathis, Mitchell V.
    Muniz, Javier
    Muoio, Brendan M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2018, 79 (03)
  • [29] Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration
    DiMagno, Sarah S. P.
    Glickman, Aaron
    Emanuel, Ezekiel J.
    JAMA INTERNAL MEDICINE, 2019, 179 (07) : 922 - 923
  • [30] Vilazodone: Clinical Basis for the US Food and Drug Administration's Approval of a New Antidepressant
    Laughren, Thomas P.
    Gobburu, Jogarao
    Temple, Robert J.
    Unger, Ellis F.
    Bhattaram, Atul
    Dinh, Phillip V.
    Fossom, Linda
    Hung, H. M. James
    Klimek, Violetta
    Lee, Jee Eun
    Levin, Robert L.
    Lindberg, Cheri Y.
    Mathis, Mitchell
    Rosloff, Barry N.
    Wang, Sue-Jane
    Wang, Yaning
    Yang, Peiling
    Yu, Bei
    Zhang, Huixia
    Zhang, Li
    Zineh, Issam
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (09) : 1166 - 1173
12345